PER 2.86% 7.2¢ percheron therapeutics limited

isis - technology - update, page-18

  1. 4,103 Posts.
    lightbulb Created with Sketch. 1866
    Hi Lok
    Good to see you hanging in there as you say good opportunity right now before results come out.

    Kevin could go either way i agree to a certain degree, but am more than swaying to the POSOTIVE side of things hence my enthusiasm to top up whenever possible before things start to move.

    Positive interim results on 1103 NOTE the word POSITIVE

    The Tox Problem as announced on 1102 with reference to TEVAS problem has been cleared up,

    All we await now are the histoligy results from the monkeys to further back our case going into the meetings with the FDA to work out a phase 2b study.

    With the good possibility of a partner in the background awaiting the outcome of these talks

    Stem cell is a bonus at this stage.

    I personally, and this is no way to be taken as fact believe that we are in talks on both fronts and look forward as Lok has mentioned above to the next few months unfolding.

    Gasy may go overboard on some of his posts but his information is on the ball, most of the time, read between the lnes, as he has previously stated we could even get fast track status on 1102.

    Enough from me for now.

    Kevin i wish you all the best with your holding would be a shame to see you go but 20+ and your in the money hey why not, profits a profit as they say.

    GO ANP

    PS for the long termers here, i did get a quick eml from Abs the other day it was short and sweet but positive towards ANP

    GO ANP


 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $64.91M
Open High Low Value Volume
7.4¢ 7.4¢ 7.0¢ $44.32K 616.8K

Buyers (Bids)

No. Vol. Price($)
1 4250 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 49809 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.